The Horizon Kinetics Medical ETF (MEDX) is structured to achieve significant long-term growth for investors. It accomplishes this by primarily focusing its investments on cutting-edge, patented pharmaceutical and biologic treatments that are considered first-line therapies. The fund aims to generate profits by recognizing and capitalizing on the inherent, underlying value of these companies, as well as benefiting from impactful advancements in medical science.